Back

Do we need a prophylactic ICD in patients with CRT indication? pro

30 March 2025 (09:00 - 09:10)
Organised by: Logo
Congress Presentation Part of: Debate on primary prevention in ICD therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sana Al-Khatib

Duke University Medical Center, Durham (United States of America)

5 More presentations in this session

Presentation thumbnail
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired ejection fraction: pro
Professor V. Kutyifa (Rochester, US)
Slides Video
Presentation thumbnail
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired LVEF: con
Doctor N. Dagres (Berlin, DE)
Slides Video
Presentation thumbnail
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy: discussion
Video
Presentation thumbnail
Do we need a prophylactic ICD in patients with CRT indication? con
Professor C. Sticherling (Basel, CH)
Slides Video
Presentation thumbnail
Do we need a prophylactic ICD in patients with CRT indication? discussion
Video

Access the full session

Session thumbnail
Debate on primary prevention in ICD therapy
Video

The Event

Event poster

EHRA 2025

30 March 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Do we need a prophylactic ICD in patients with CRT indication? con
thumbnail
Congress Presentation
Do we need a prophylactic ICD in patients with CRT indication? discussion
thumbnail
Congress Presentation
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired ejection fraction: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources